Welcome video from Prof. Ringshausen,
Organising Committee Co-Chair
Welcome
Dear Colleagues & Friends,
A decade after the inaugural World Bronchiectasis Conference in Hannover – brought to us by the determination and dedication of the brilliant Professor Tobias Welte, our community returns to the city where this dynamic global movement was born.
Over these ten years, bronchiectasis has moved from the margins to the mainstream. International registries have transformed our understanding of disease burden and phenotypes: updated guidelines and consensus statements have clarified standards of care; new clinical trials have tested anti‑inflammatory and anti‑infective treatment strategies; airway clearance and physiotherapy have dispersed; and advances in digital health, imaging and microbiome research are about to reshape how we monitor, personalise and prevent exacerbations. Most importantly, the patient voice is now more firmly embedded in research priorities and service design than ever before.
Uniting global expertise to shape better patient outcomes
WBC 2026 will once again gather clinicians, scientists, allied health professionals, industry partners and patients to translate this progress into better patient outcomes.
The programme will feature cutting‑edge sessions on treatable traits and endotypes, infection and NTM management, precision diagnostics, physiotherapy and rehabilitation, AI-enabled tools, and late-breaking clinical trials.
This year we have several parallel tracks including basic science, paediatrics, the perspectives of allied health professionals, PCD, NTM, and a dedicated German-language session on outpatient bronchiectasis care. For the first time at WBC, the main programme will also feature a dedicated track exploring the psychosocial impact of bronchiectasis on patients. In addition, two half-days of patient–professional discussions will offer practical, hands-on strategies for disease management.
The next generation of bronchiectasis experts
The theme of the 9th World Bronchiectasis Conference 2026 is “Paving The Way For The Next Generation”. Early-career professionals sit at the heart of WBC 2026, with a wide range of dedicated activities designed to build skills, spark new ideas, and inspire confidence. Full details can be found in the programme.
A homecoming: shaping another decade of bronchiectasis care
Hannover represents both a symbolic homecoming and a defining moment for our field – an opportunity to celebrate and work together to set the agenda for the decade ahead.
At WBC 2026, we will strengthen cross-disciplinary collaboration, amplify the patient voice, empower the next generation, accelerate therapeutic development, and collectively push for equitable access to high-quality bronchiectasis care worldwide.
Â
We invite you to join us in Hannover, 24–27 June 2026, to advance science, elevate clinical practice and improve the lives of people living with bronchiectasis.
Francesco Blasi, James Chalmers, Jessica Rademacher, Felix C. Ringshausen
WBC 2026 Organising Committee
Hannover, Germany
Organising Committee
Francesco Blasi
(Italy)
Francesco Blasi
(Italy)
Francesco Blasi, MD, FERS is Professor of Respiratory Medicine in the Department of Pathophysiology and Transplantation at the University of Milan, Italy, as well as Head of Internal Medicine Department and Respiratory Unit of the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy. He is also director of the Adult Cystic Fibrosis Center of the Lombardia Regional Referral CF Center and currently a member of the Board of Directors of the University of Milan. From 2012–2013, he was president of European Respiratory Society (ERS) and from 2016–2017 president of the Italian Respiratory Society (SIP/IRS). From 2017–2018, he was president of the Italian Respiratory Society Research Center (SIP/IRS Centro Ricerche). Professor Blasi has published more than 350 papers in international journals (WEB of Science (01.12.2018) h-index : 50 Citations: 8620; SCOPUS (01.12.2018) : h-index:53 Citations:10680 ; Google Scholar (1.4.2019): h-index: 70, Citations: 17,668). His research interests include pneumonia, COPD, bronchiectasis, tuberculosis and NTM infections, cystic fibrosis and lung transplantation.
James Chalmers
(United Kingdom)
James Chalmers
(United Kingdom)
Asthma and Lung UK Chair of Respiratory Research, University of Dundee Chief Editor, European Respiratory Journal Chair, Science and Research Committee, British Thoracic Society Chair, European Bronchiectasis Registry (EMBARC)
Jessica Rademacher
(Germany)
Jessica Rademacher
(Germany)
Pneumologie Süderelbe, Private Practice Hamburg
Medical School Hannover, Department of Respiratory Medicine and Infectious Diseases
Professor Jessica Rademacher is a specialist in internal medicine, pulmonology, and infectious diseases. She erves on the board of the German Bronchiectasis Registry (PROGNOSIS). Since 2007 she has been an active member of the national community-acquired pneumonia network (CAPNETZ), and in 2025 she joined its executive board. In the same year, she took over leadership of a major pulmonology practice in Hamburg, where she combines clinical care with her ongoing research focus on respiratory infections and bronchiectasis.
Specialist in Internal Medicine, Pulmonology, and Infectious Diseases with a strong clinical and academic track record.
Lead of the Antibiotic Stewardship (ABS) Program at Hannover Medical School (MHH), driving evidence-based antimicrobial use (2018-2024).
Long-standing member of CAPNETZ (since 2007), one of Germany’s largest pneumonia research networks.
First author, German S3-Guideline for Nosocomial Pneumonia
Elected to the CAPNETZ Executive Board in 2025, contributing to national strategy in pneumonia research.
Board member of the German Bronchiectasis Registry (PROGNOSIS) with a focus on rare respiratory diseases.
Head of a major pulmonology practice in Hamburg since 2025, integrating high-level clinical care with research expertise.
- 2007 – Member, CAPNETZ (Community-Acquired Pneumonia Network)
- 2012 – Specialist in Internal Medicine and Infectious Diseases (MHH)
- 2015 – Specialist in Pulmonology (MHH)
- 2016 – Lead, Antibiotic Stewardship (ABS) Program, Hannover Medical School
- 2019 – Board Member, German Bronchiectasis Registry (PROGNOSIS)
- 2024 – First author, German S3-Guideline for Nosocomial Pneumonia
- 2025 – Executive Board Member, CAPNETZ • 2025 – Head of a major pulmonology practice in Hamburg
Areas of research: -Bronchiectasis
- Non-tuberculous Mycobacteria
-pneumonia
-Primary ciliary dyskinesia
-Antimicrobial stewardship
Felix Ringshausen
(Germany)
Felix Ringshausen
(Germany)
Felix C. Ringshausen is a board-certified physician for respiratory medicine and infectious diseases and head of the Adult Bronchiectasis and Cystic Fibrosis Service at the Hannover Medical School, Germany. In addition, he is principal investigator of the German Center for Lung Research (DZL). His research interests are focused on European multidisciplinary networks and multicenter initiatives in order to promote clinically orientated research and improve patient care in the field of rare, neglected and under-researched aspects of respiratory infections like bronchiectasis, nontuberculous mycobacteria, respiratory viruses and adult cystic fibrosis.
Organising Association
Important dates
CALL FOR ABSTRACTS CLOSING
27 March 2026
EARLY REGISTRATION DEADLINE
18 April 2026
Topics
Dive into key topics at the World Bronchiectasis Conference, where we explore the complexities of bronchiectasis from its causes and underlying mechanisms to innovative treatments.
Engage with cutting-edge research on genomics, diverse infections, the impact of environmental factors, and the latest therapeutic strategies.
Join global experts in addressing critical aspects of respiratory health in Hannover.
Basic Science
(aetiology & pathophysiology)
Clinical Trials
Comorbidities
(AATD, Asthma, COPD, etc.)
Cystic Fibrosis and Bronchiectasis
Immunology & Inflammation
(including ABPA, inborn errors of immunity, primary
immunodeciency, neutrophil function/dysfunction)
Infections
(Pseudomonas, Haemophilus, etc.)